Skip to main content
Clinical Trials/NCT07520825
NCT07520825
Active, not recruiting
Not Applicable

Laser Photobiomodulation in Addition to Standard-of-care for Hard-to-heal Ulcers in Frail Older Adults With Municipality Home Healthcare

Umeå University1 site in 1 country1,290 target enrollmentStarted: September 1, 2020Last updated:

Overview

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
1,290
Locations
1
Primary Endpoint
Healing time: Time in days from initiation of PBM/(baseline registration) until healing.

Overview

Brief Summary

The aim of this quasi-experimental prospective study is to evaluate the effectiveness of photobiomodulation treatment on hard-to-heal ulcers of various diagnosed aetiologies in frail older adults, admitted to municipal home healthcare. The study also include evaluation of cost-effectiveness, and healthcare providers experiences of treating frail older adults hard-to-heal ulcers with photobiomodulation treatment in home healthcare.

Detailed Description

The study is a prospective quasi-experimental study with non-randomized matched control groups, from the Swedish RiksSår registry for ulcer treatment. The health economic evaluation will be based on the results from the photobiomodulation treatment (PBM) study, including data extraction from patient records. The healthcare professionals' experiences will be investigated through interviews.

Research questions

  1. Does PBM treatment reduce the healing time of hard-to-heal ulcer with defined aetiology, compared to standard-of-care treatment in frail older adults?
  2. Are factors such as sex, age, number of comorbid conditions, ulcer area, ulcer duration, and physical function associated with healing time?
  3. What is the recurrence rate of hard-to-heal ulcers of respective aetiology at 6, 12, 18, and 24 months after healing with PBM?
  4. How does patients self-assess pain and ulcer-related restraints during the photobiomodulation treatment period?
  5. Is PBM treatment of hard-to-heal ulcers cost-effective compared to standard-of-care treatment in frail older adults?
  6. How does healthcare provider experience treating hard-to-heal ulcers in frail older adults with PBM?

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Intervention Arm:
  • Individual with hard-to-heal ulcer diagnosed with a defined aetiology, treated in municipal home healthcare.
  • Assessed as eligible by primary care nurse and physician.
  • Consent to treatment with photobiomodulation.
  • Consent to the research study.
  • Inclusion Criteria Control Arm:
  • Individual with hard-to-heal ulcer diagnosed with a defined aetiology, registered in the RiksSår registry.
  • Consented to use registry information in ulcer related research.

Exclusion Criteria

  • Intervention Arm:
  • Individual with ulcers not classified as hard-to-heal ulcer.
  • Individual with hard-to-heal ulcer not diagnosed with defined aetiology.
  • Individual not treated for hard-to-heal ulcer in home healthcare.
  • Individual not consenting to research study.
  • Exclusion Criteria Control Arm:
  • Individual with ulcers not classified as hard-to-heal ulcer.
  • Individual with hard-to-heal ulcer not diagnosed with defined aetiology.

Arms & Interventions

Photobiomodulation

Experimental

Photobiomodulation group, with hard-to-heal ulcer diagnosed with a defined aetiology, treated in municipal home healthcare

Intervention: Photobiomodulation (Procedure)

Control group

Active Comparator

Control groups from the RiksSår registry, with hard-to-heal ulcer diagnosed with a defined aetiology

Intervention: Standard-of-care ulcer dressing (Procedure)

Outcomes

Primary Outcomes

Healing time: Time in days from initiation of PBM/(baseline registration) until healing.

Time Frame: From start of treatment/registration and until the date of either healed ulcer or interrupted treatment/death assessed for up to 1000 days.

Healing defined as intact skin in the previous ulcer area.

Propotion of healed ulcers compared to other ulcer treatment events.

Time Frame: From start of treatment/registration and until the date of either healed ulcer or interrupted treatment/death assessed for up to 1000 days.

Ulcers are either healed or censored due to death, amputation, or interrupted treatment.

Secondary Outcomes

  • Ulcer recurrence after healing with photobiomodulation treatment(Controlled in patient records 6, 12, 18, and 24 months after healing with photobiomodulation treatment.)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials